617 related articles for article (PubMed ID: 8864158)
1. Depression and endocrine disorders: focus on the thyroid and adrenal system.
Musselman DL; Nemeroff CB
Br J Psychiatry Suppl; 1996 Jun; (30):123-8. PubMed ID: 8864158
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of psychoneuroendocrinology in psychiatry: focus on the thyroid and adrenal.
Nemeroff CB
J Clin Psychiatry; 1989 May; 50 Suppl():13-20; discussion 21-2. PubMed ID: 2654128
[TBL] [Abstract][Full Text] [Related]
3. The stress system in the human brain in depression and neurodegeneration.
Swaab DF; Bao AM; Lucassen PJ
Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
[TBL] [Abstract][Full Text] [Related]
4. [The relation between results of thyrotropin-releasing hormone stimulation tests (TRH-ST), dexamethasone suppression test (DST) and urinary MHPG. SO4 excretion in depressive patients].
Chen G
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Aug; 24(4):203-6, 251. PubMed ID: 1954790
[TBL] [Abstract][Full Text] [Related]
5. Endocrine dysfunction in anorexia nervosa and bulimia: comparison with abnormalities in other psychiatric disorders and disturbances due to metabolic factors.
Hudson JI; Hudson MS
Psychiatr Dev; 1984; 2(4):237-72. PubMed ID: 6098898
[TBL] [Abstract][Full Text] [Related]
6. Alterations in hypothalamic-pituitary-adrenal/thyroid (HPA/HPT) axes correlated with the clinical manifestations of depression.
Min W; Liu C; Yang Y; Sun X; Zhang B; Xu L; Sun X
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):206-11. PubMed ID: 22750689
[TBL] [Abstract][Full Text] [Related]
7. The thyrotropin-releasing hormone test may predict recurrence of clinical depression within ten years after discharge.
Tsuru J; Ishitobi Y; Ninomiya T; Kanehisa M; Imanaga J; Inoue A; Okamoto S; Maruyama Y; Higuma H; Tanaka Y; Hanada H; Isogawa K; Akiyoshi J
Neuro Endocrinol Lett; 2013; 34(5):409-17. PubMed ID: 23922049
[TBL] [Abstract][Full Text] [Related]
8. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
Ströhle A
Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
[TBL] [Abstract][Full Text] [Related]
9. [Limbic-hypothalamic-pituitary-adrenal axis in depression: literature review].
Twardowska K; Rybakowski J
Psychiatr Pol; 1996; 30(5):741-55. PubMed ID: 8984515
[TBL] [Abstract][Full Text] [Related]
10. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
[TBL] [Abstract][Full Text] [Related]
11. [Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid axis findings in depressive disorder].
Sarandöl A; Taneli B; Sivrioğlu Y
Turk Psikiyatri Derg; 2003; 14(2):116-24. PubMed ID: 12844278
[TBL] [Abstract][Full Text] [Related]
12. Hypercortisolemia and depression.
Gillespie CF; Nemeroff CB
Psychosom Med; 2005; 67 Suppl 1():S26-8. PubMed ID: 15953796
[TBL] [Abstract][Full Text] [Related]
13. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
[TBL] [Abstract][Full Text] [Related]
14. Hypofunction of the stress axis in Sjögren's syndrome.
Johnson EO; Vlachoyiannopoulos PG; Skopouli FN; Tzioufas AG; Moutsopoulos HM
J Rheumatol; 1998 Aug; 25(8):1508-14. PubMed ID: 9712092
[TBL] [Abstract][Full Text] [Related]
15. The hypothalamic-pituitary-adrenal axis in depression.
Meltzer HY; Lowy MT; Koenig JI
Adv Biochem Psychopharmacol; 1987; 43():165-82. PubMed ID: 3035885
[No Abstract] [Full Text] [Related]
16. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
[TBL] [Abstract][Full Text] [Related]
18. The neurobiological basis of mixed depression-anxiety states.
Gulley LR; Nemeroff CB
J Clin Psychiatry; 1993 Jan; 54 Suppl():16-9. PubMed ID: 8093884
[TBL] [Abstract][Full Text] [Related]
19. Hormonal differences between psychotic and non-psychotic melancholic depression.
Contreras F; Menchon JM; Urretavizcaya M; Navarro MA; Vallejo J; Parker G
J Affect Disord; 2007 Jun; 100(1-3):65-73. PubMed ID: 17098292
[TBL] [Abstract][Full Text] [Related]
20. [Hypophyseal-hypothalamo-thyroid axis in affective disorders].
Hofmann P; Schrötter KH
Acta Med Austriaca; 1999; 26(4):123-5. PubMed ID: 10526629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
